Add to a list

Inactive Instrument

Nvest Inc. Stock Other OTC

MJVP

US67075X1063

Pharmaceuticals

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

NutraProducts Inc. is a contract manufacturer specializing in the production of gummy supplements that are vegan, and free from allergens and gluten. The Company also offers comprehensive services, including product development, packaging, labeling, and third-party logistics (3PL). Utilizing starch-less mold technology, the Company ensures a contaminant-free environment, delivering products that meet stringent quality standards. Its products include Gummies, Drinks, and Bulk Ingredients. Its ready-to-drink, private-labeled formulations are shelf-stable, customizable, and designed for maximum flavor and function. It also offers a wide range of bulk ingredients, including functional compounds and custom blends, ready for use. Its Gummies are custom formulated with precise dosing and clean ingredients.

Employees

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

Market Cap	592K 516K 475K 447K 837K 55.79M 843K 5.66M 2.2M 27.5M 2.22M 2.17M 95.3M	P/E 2014	-13.1x	P/E 2015	-11.3x
Enterprise Value	547K 476K 439K 413K 773K 51.54M 778K 5.23M 2.03M 25.4M 2.05M 2.01M 88.04M	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.61%	Yield 2014 *	-	Yield 2015	-

18-05-17	MJ Venture Partners, Inc. Appoints Brett H. Pojunis as Chairman and Chief Executive Officer	CI
18-04-10	GoTraq Inc. will Change its Name to MJ Venture Partners, Inc	CI
18-04-10	MJ Venture Partners, Inc. has Changed its Ticker to MJVP from GTRQ	CI
15-11-12	Traack Technologies Inc. Auditor Raises 'Going Concern' Doubt	CI
15-08-25	GeoTraq, Inc. Launches Cell-ID Device Management Platform	CI
15-08-11	GeoTraq Seeks Acquisitions	CI
15-08-10	GeoTraq Inc. terminated the acquisition of Ci2i Services, Inc. and OmniM2M LLC.	CI
15-08-05	GeoTraq Announces Successful Testing of the G-200 Cell-ID Module in Both Lab and Real World Testing	CI
15-07-27	GeoTraq Inc. entered into a letter of intent to acquire Ci2i Services, Inc. and OmniM2M LLC for $10.8 million.	CI
15-06-02	GeoTraq Inc. Files Patent Application for First Cell-ID Module	CI
14-12-31	GeoTraq Inc. Announces Management Changes	CI
14-12-22	GeoTraq Inc. Creates Cell-ID Transceiver Module	CI
14-04-08	GeoTraq Inc. Appoints Gregg Sullivan as President, Chief Executive Officer, Chief Financial Officer and Director	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NVEST INC.	+2.14%	-.--%	-	-	7.95M
ELI LILLY AND COMPANY	-1.21%	-5.37%	+39.94%	+145.38%	992B
JOHNSON & JOHNSON	-2.48%	-4.17%	+51.52%	+39.07%	564B
ABBVIE INC.	-2.14%	-3.68%	+16.71%	+56.15%	391B
ROCHE HOLDING AG	-1.18%	+0.25%	+25.86%	+16.53%	330B
ASTRAZENECA PLC	-2.36%	-3.12%	+24.71%	+11.59%	280B
NOVARTIS AG	-2.45%	-2.88%	+24.29%	+30.06%	279B
NOVO NORDISK A/S	-1.91%	-0.87%	-41.95%	-49.25%	196B
AMGEN INC.	-1.19%	-4.65%	+16.56%	+47.00%	184B
GILEAD SCIENCES, INC.	-1.35%	-1.68%	+14.59%	+56.94%	156B
Average	-1.41%	-1.98%	+19.14%	+39.27%	374.58B
Weighted average by Cap.	-1.77%	-2.88%	+28.03%	+63.21%

	2014	2015
Net sales	-	-
Net income	-311K -271K -250K -235K -440K -29.31M -443K -2.97M -1.15M -14.44M -1.17M -1.14M -50.07M	-506K -441K -407K -383K -716K -47.72M -721K -4.84M -1.88M -23.52M -1.9M -1.86M -81.51M
Net Debt	397K 346K 319K 300K 561K 37.4M 565K 3.79M 1.47M 18.43M 1.49M 1.46M 63.88M	-45.13K -39.32K -36.25K -34.09K -63.79K -4.25M -64.23K -431K -167K -2.1M -169K -166K -7.27M

Nvest Inc. Stock Other OTC

Stocks

MJVP

US67075X1063

Pharmaceuticals

Valuation: Nvest Inc.

Latest news : Nvest Inc.

Quotes and Performance

Managers and Directors: Nvest Inc.

Other Pharmaceuticals

Financials

Company Profile